Archive · 31 Aug 2026
Argentina Eases Path for Indian Pharma and Farm Exports
Argentina says it wants to make it easier for Indian medicine companies to enter its market.
It will work on changing India’s regulatory classification from Annex II to Annex I. This could give Indian pharmaceutical companies more business opportunities.
It may also help people in Argentina get quality medicines at affordable prices.
The countries are discussing easier access for Indian farm products, too.
India and Argentina traded more than $6.5 billion in 2025.
They also talked about lithium mining, energy and infrastructure projects.
Both sides discussed technology areas such as aviation, space, artificial intelligence and digital services.
Argentina committed to reducing barriers for Indian pharmaceutical products and companies.
Buenos Aires will work to upgrade India from Annex II to Annex I under its pharmaceutical regulatory framework.
India and Argentina also reported progress toward facilitating Indian agricultural exports into Argentina.
Bilateral trade exceeded $6.5 billion in 2025, with annual growth of more than 17 percent.
The countries discussed lithium, energy, infrastructure, aviation, space technology, telecommunications and digital services.
- Who
- India and Argentina, including Indian Commerce Secretary Rajesh Agarwal and Indian pharmaceutical and agricultural companies.
- What
- Argentina committed to reducing pharmaceutical market-entry barriers and working to upgrade India from Annex II to Annex I.
- When
- The discussions took place during the week of the India-Argentina Joint Trade Committee meeting on August 24, 2026.
- Where
- Palacio San Martín in Buenos Aires, Argentina.
- Why
- The measures are intended to expand opportunities for Indian businesses, improve access to medicines and agricultural products, and make bilateral trade more efficient.
- Pharmaceutical access
- Argentina committed to reducing barriers to entry for Indian pharmaceutical products and companies.
- Regulatory classification
- Argentina will work toward upgrading India from Annex II to Annex I under its pharmaceutical regulatory framework.
- Bilateral trade
- India-Argentina trade exceeded $6.5 billion in 2025.
- Trade growth
- Bilateral trade recorded annual growth of more than 17 percent.
- Agricultural access
- The countries reported progress toward facilitating Indian agricultural exports into Argentina.
- Lithium project
- KABIL completed Phase II drilling at its lithium project in Catamarca.
- Mercosur agreement
- India and Mercosur are seeking to expand their preferential trade agreement, which took effect on June 1, 2009.
- Trade facilitation
- Digital certificates of origin and progress on the agreement’s Terms of Reference are expected to make cross-border commerce more efficient.
